Federica Bottiglione
An altered metasystem linking the gut microbiota and systemic immune response could lead to impaired host defense and increased vulnerability to hospital-acquired infections in cases of severe illness.
ETX-producing C. perfringens strains are biologically plausible pathogens in MS that trigger inflammatory demyelination.
The findings of a recent study reveal that P. distasonis and its metabolites could be promising candidates for treating RA.
Numerous evidences demonstrate the involvement of the sex hormone-gut microbiome axis in regulating the antitumor efficacy of ICIs.
The study reveals a connection between gut microbiome changes and the most prevalent form of alcohol misuse in adolescence, occurring even before the onset of addiction.
Collaborative initiatives would be needed to detect subtle associations and understand the role of the gut microbiome in the development of psychiatric symptoms over time.
Specific gut bacteria and/or metabolites could be responsible for the differential responses to weight management.
A recent study suggests that SCFA production is associated with a restoration of intestinal homeostasis and sustained remission in CD patients.
